Citation Impact
Citing Papers
Sulfur [ 18 F]Fluoride Exchange Click Chemistry Enabled Ultrafast Late-Stage Radiosynthesis
2021 StandoutNobel
Strategies and tools for the control/elimination of lymphatic filariasis.
1997 Standout
Revised American Thyroid Association Management Guidelines for Patients with Thyroid Nodules and Differentiated Thyroid Cancer
2009 Standout
Management Guidelines for Children with Thyroid Nodules and Differentiated Thyroid Cancer
2015 Standout
2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer: The American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer
2015 Standout
The CONSORT statement: revised recommendations for improving the quality of reports of parallel group randomized trials
2001 Standout
Current Approaches to Primary Therapy for Papillary and Follicular Thyroid Cancer
2001 Standout
Identifying active vascular microcalcification by 18F-sodium fluoride positron emission tomography
2015
Dosimetric Considerations in the Radioiodine Treatment of Macrometastases and Micrometastases from Differentiated Thyroid Cancer
1997
THYROID CANCER IN CHILDREN, PREGNANT WOMEN, AND PATIENTS WITH GRAVES' DISEASE
1996
Skeletal PET with18F-Fluoride: Applying New Technology to an Old Tracer
2007
Differentiated thyroid carcinomas in children and adolescents
1991
Use of Decision Analysis in Planning a Management Strategy for the Stage NO Neck
1994 Standout
Influence of 131I diagnostic dose on subsequent ablation in patients with differentiated thyroid carcinoma: discrepancy between the presence of visually apparent stunning and the impairment of successful ablation
2004
Enzyme-Linked Immunosorbent Assay for the Detection of Antibodies Against Mycobacterium tuberculosis in Bronchial Washings and Serum
1988
A case of stunning of lung and bone metastases of papillary thyroid cancer after a therapeutic dose (3.7 GBq) of131I and review of the literature: implications for sequential treatments
2005
Influence of Diagnostic Radioiodines on the Uptake of Ablative Dose of Iodine-131
1994
European consensus for the management of patients with differentiated thyroid carcinoma of the follicular epithelium
2006 Standout
Oxazolidinones: activity, mode of action, and mechanism of resistance
2004 Standout
Recurrent/metastatic thyroid carcinomas false negative for serum thyroglobulin but positive by posttherapy I-131 whole body scans
2008
Atherosclerosis
2019 Standout
Diagnosis and Treatment of Tuberculous Pleural Effusion in 2006
2007 Standout
Oxazolidinones, a new class of synthetic antituberculosis agent in vitro and in vivo activities of DuP-721 against Mycobacterium tuberculosis
1991
Salivary cortisol in psychoneuroendocrine research: Recent developments and applications
1994 Standout
SERUM THYROGLOBULIN MEASUREMENT
2001
Chemistry and biology of siderophores
2010 Standout
Testicular dose and fertility in men following I131 therapy for thyroid cancer
2002
131-I treatment of micronodular pulmonary metastases from papillary thyroid carcinoma
1996
2 Clinically Useful Chelators of Tripositive Elements
1991
Diagnostic value of serum thyroglobulin measurements in the follow‐up of differentiated thyroid carcinoma, a structured meta‐analysis
2004
Detection of Thyroid Remnant/Metastasis Without Stunning: An Ongoing Dilemma
1997
Management Guidelines for Patients with Thyroid Nodules and Differentiated Thyroid Cancer: The American Thyroid Association Guidelines Taskforce
2006 Standout
Current Controversies in the Management of Pediatric Patients with Well-Differentiated Nonmedullary Thyroid Cancer: A Review
2002
2016 American Thyroid Association Guidelines for Diagnosis and Management of Hyperthyroidism and Other Causes of Thyrotoxicosis
2016 Standout
Radioiodine or Surgery for Toxic Thyroid Adenoma: Dissecting an Important Decision. A Cost-Effectiveness Analysis
2004
Immunological aspects of lymphatic filariasis and onchocerciasis in man
1984
Hormones in Saliva
1986
Clinical utility of posttreatment radioiodine scans in the management of patients with thyroid carcinoma.
1994
Intermediate, Indeterminate, and Uninterpretable Diagnostic Test Results
1987
The Nonimpact of Thyroid Stunning: Remnant Ablation Rates in 131I-Scanned and Nonscanned Individuals
2001
STARD 2015 guidelines for reporting diagnostic accuracy studies: explanation and elaboration
2016 Standout
Lithium as a Potential Adjuvant to 131I Therapy of Metastatic, Well Differentiated Thyroid Carcinoma1
1999
Antipurified-Protein-Derivative Antibody in Tuberculous Pleural Effusions
1990 StandoutNobel
Local reactions to radioiodine in the treatment of thyroid cancer
1991
Impact of 131I diagnostic activities on the biokinetics of thyroid remnants.
2004
Current status and performance goals for serum thyroglobulin assays
1996
Current Strategies for Surgical Management and Adjuvant Treatment of Childhood Papillary Thyroid Carcinoma
2004
The Nonimpact of Thyroid Stunning: Remnant Ablation Rates in 131I-Scanned and Nonscanned Individuals
2001
Outcome of 309 patients with metastatic differentiated thyroid carcinoma treated with radioiodine
1994
Local reactions to radioiodine in the treatment of thyroid cancer
1991
Guidelines for the management of thyroid cancer
2014 Standout
Factors Influencing the Basal and Recombinant Human Thyrotropin-Stimulated Serum Thyroglobulin in Patients with Metastatic Thyroid Carcinoma
2004
Radioiodsne-131 In the Diagnosis and Treatment of Metastatic Weil Differentiated Thyroid Cancer
1990
No Adverse Affect in Clinical Outcome Using Low Preablation Diagnostic 131I Activity in Differentiated Thyroid Cancer: Refuting Thyroid-Stunning Effect
2014
Efficacy of Diethylcarbamazine in Eradicating Infection with Lymphatic-Dwelling Filariae in Humans
1985
TESTICULAR DAMAGE AFTER RADIOACTIVE IODINE (I‐131) THERAPY FOR THYROID CANCER
1983
Iodine Biokinetics and Radioiodine Exposure after Recombinant Human Thyrotropin-Assisted Remnant Ablation in Comparison with Thyroid Hormone Withdrawal
2010
Predicting the efficacy of first iodine-131 treatment in differentiated thyroid carcinoma.
1997
Thyroid carcinoma
2003 Standout
Metastatic Differentiated Thyroid Carcinoma: ClinicopathologicalProfile and Outcome in an Iodine Deficient Area
2002
Systematic reviews: CRD's guidance for undertaking reviews in health care
2010 Standout
Decision Analysis: A Progress Report
1987
The success of 131I ablation in thyroid cancer patients is significantly reduced after a diagnostic activity of 40 MBq 131I
2009
Works of R.D. Ganatra being referenced
Cell mediated and humoral immune response in tropical eosinophilia.
1978
Influence of initial large dose on subsequent uptake of therapeutic radioiodine in thyroid cancer patients
1986
Cost-Effectiveness of Screening for Hypo- and Hyperthyroidism in India
1981
Significance of circulating immune complexes in pulmonary tuberculosis.
1984
Evaluation of tubercular antigen & antitubercular antibodies in pleural & ascitic effusions.
1984
18F-fluoride for bone imaging
1972
An unusual site of radioiodine concentration in a patient with thyroid cancer.
1972
Diethylcarbamazine (hetrazan) in tropical eosinophilia.
1958
Radioiodine in treatment of metastatic thyroid cancer
1979
Modifications in biphasic liquid-scintillation vial system for radiometry.
1980
A simple and safer 113mIn colloid preparation for scanning the liver
1970
Immunoreactive thyroglobulin-like material derived from saliva
1983
Disappearance rate of endogenously radioiodinated thyroglobulin and thyroxine after radioiodine treatment
1982
Serum thyroglobulin in differentiated thyroid carcinoma: histological and metastatic classification
1981